147 related articles for article (PubMed ID: 20351319)
21. Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.
Wang H; Wang L; Li C; Wuxiao Z; Chen G; Luo W; Lu Y
Oncologist; 2020 Nov; 25(11):e1725-e1731. PubMed ID: 32627928
[TBL] [Abstract][Full Text] [Related]
22. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
23. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
24. [Curative effect of nasal type extranodal NK/T-cell lymphoma by sequential chemotherapy combined radiotherapy compared with chemotherapy].
Wang C; Bai H; Xi R; Pan Y; Xu S; Zhang Q; Chen Y; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 27(23):1283-6, 1290. PubMed ID: 24620654
[TBL] [Abstract][Full Text] [Related]
25. Nasal-type extranodal natural killer/T-cell lymphoma presenting with abundant plasma cell: a case report.
Zhong D; Guo D; Wan X; Jiang X; Shi X; Lei G; Yan X
J Clin Oncol; 2011 Jul; 29(21):e620-2. PubMed ID: 21576643
[No Abstract] [Full Text] [Related]
26. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
Kim TH; Kim JS; Suh YG; Cho J; Yang WI; Suh CO
Yonsei Med J; 2016 Jul; 57(4):846-54. PubMed ID: 27189276
[TBL] [Abstract][Full Text] [Related]
27. Extranodal sinonasal natural killer/T-cell lymphoma presenting as chronic sinusitis and necrotic wound infection.
Karaman E; Yilmaz M; Alimoglu Y; Edizer DT; Isildak H; Ozek H
J Craniofac Surg; 2009 Nov; 20(6):2095-6. PubMed ID: 19881363
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.
Kim SJ; Yang DH; Kim JS; Kwak JY; Eom HS; Hong DS; Won JH; Lee JH; Yoon DH; Cho J; Nam TK; Lee SW; Ahn YC; Suh C; Kim WS
Ann Hematol; 2014 Nov; 93(11):1895-901. PubMed ID: 24947798
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Hotta T; Tsukasaki K; Oshimi K
J Clin Oncol; 2012 Nov; 30(32):4044-6. PubMed ID: 23045573
[No Abstract] [Full Text] [Related]
30. Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A; Hermine O
Curr Opin Oncol; 2011 Sep; 23(5):429-35. PubMed ID: 21743325
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Deng XW; Wu JX; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Dong M; Qi SN; Yang Y; Li YX
Radiother Oncol; 2018 Oct; 129(1):3-9. PubMed ID: 29739712
[TBL] [Abstract][Full Text] [Related]
32. Extranodal natural killer/T cell lymphoma: we should and we can do more.
Ying Z; Zhu J
Chin Clin Oncol; 2015 Mar; 4(1):12. PubMed ID: 25841719
[TBL] [Abstract][Full Text] [Related]
33. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
Kwong YL; Kim SJ; Tse E; Oh SY; Kwak JY; Eom HS; Do YR; Mun YC; Lee SR; Shin HJ; Suh C; Chuang SS; Lee YS; Lim ST; Izutsu K; Suzuki R; Relander T; d'Amore F; Schmitz N; Jaccard A; Kim WS
Ann Oncol; 2018 Jan; 29(1):256-263. PubMed ID: 29077846
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.
Bi XW; Jiang WQ; Zhang WW; Huang JJ; Xia Y; Wang Y; Sun P; Li ZM
Ann Hematol; 2015 Jul; 94(7):1175-84. PubMed ID: 25687842
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
[TBL] [Abstract][Full Text] [Related]
36. [Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management].
Dağoğlu RN; Ozdemir O; Ergen A; Ağaoğlu FY
Kulak Burun Bogaz Ihtis Derg; 2012; 22(3):164-71. PubMed ID: 22663927
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK/T cell lymphoma.
Kim SY; Cho SG; Kim SW; Choi BO; Park KS; Lim J; Min CK; Kim YG; Lee JW; Min WS
Ann Hematol; 2011 Jun; 90(6):693-9. PubMed ID: 21088967
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
39. The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis.
Jiang L; Li SJ; Jiang YM; Long JX; Wang RS; Su J; Zhang Y
Leuk Lymphoma; 2014 May; 55(5):1038-48. PubMed ID: 23885795
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
